Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Leonard

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Clinical Breast Cancer|June 14, 2011
Human epidermal growth factor receptor 2-positive breast cancer relapsing post-adjuvant trastuzumab: pattern of recurrence, treatment and outcomeJonathan Krell, Colin R James, Deep Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2002
Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial resultsJoyce O'Shaughnessy, David Miles, Svetislava Vukelja, et al.
British Journal of Cancer|September 13, 2018
Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I studySarah P Blagden, Ivana Rizzuto, Puvan Suppiah, et al.
Diagnostics (Basel, Switzerland)|February 24, 2024
Prediction of Intrauterine Growth Restriction and Preeclampsia Using Machine Learning-Based Algorithms: A Prospective StudyIngrid-Andrada Vasilache, Ioana-Sadyie Scripcariu, Bogdan Doroftei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase III trialJean-Marc Nabholtz, Carla Falkson, Daniel Campos, et al.
Clinical Breast Cancer|May 17, 2011
Management and outcome of HER2-positive early breast cancer treated with or without trastuzumab in the adjuvant trastuzumab eraCarlo Palmieri, Deep Shah, Jonathan Krell, et al.
Cancers|July 27, 2022
Accurate Screening for Early-Stage Breast Cancer by Detection and Profiling of Circulating Tumor CellsTimothy Crook, Robert Leonard, Kefah Mokbel, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|June 10, 2015
Clinical Course of Vitreomacular Traction Managed Initially by ObservationJonathan H Tzu, Vishak J John, Harry W Flynn, et al.
BMJ Open|August 2, 2017
Bridging the age gap in breast cancer: evaluation of decision support interventions for older women with operable breast cancer: protocol for a cluster randomised controlled trialKaren Collins, Malcolm Reed, Kate Lifford, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Clinical Breast Cancer|June 14, 2011
Human epidermal growth factor receptor 2-positive breast cancer relapsing post-adjuvant trastuzumab: pattern of recurrence, treatment and outcomeJonathan Krell, Colin R James, Deep Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2002
Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial resultsJoyce O'Shaughnessy, David Miles, Svetislava Vukelja, et al.
British Journal of Cancer|September 13, 2018
Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I studySarah P Blagden, Ivana Rizzuto, Puvan Suppiah, et al.
Diagnostics (Basel, Switzerland)|February 24, 2024
Prediction of Intrauterine Growth Restriction and Preeclampsia Using Machine Learning-Based Algorithms: A Prospective StudyIngrid-Andrada Vasilache, Ioana-Sadyie Scripcariu, Bogdan Doroftei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase III trialJean-Marc Nabholtz, Carla Falkson, Daniel Campos, et al.
Clinical Breast Cancer|May 17, 2011
Management and outcome of HER2-positive early breast cancer treated with or without trastuzumab in the adjuvant trastuzumab eraCarlo Palmieri, Deep Shah, Jonathan Krell, et al.
Cancers|July 27, 2022
Accurate Screening for Early-Stage Breast Cancer by Detection and Profiling of Circulating Tumor CellsTimothy Crook, Robert Leonard, Kefah Mokbel, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|June 10, 2015
Clinical Course of Vitreomacular Traction Managed Initially by ObservationJonathan H Tzu, Vishak J John, Harry W Flynn, et al.
BMJ Open|August 2, 2017
Bridging the age gap in breast cancer: evaluation of decision support interventions for older women with operable breast cancer: protocol for a cluster randomised controlled trialKaren Collins, Malcolm Reed, Kate Lifford, et al.
Pageof 4